Bio-Rad Laboratories (BIO) Retained Earnings (2009 - 2026)
Bio-Rad Laboratories' (BIO) quarterly Retained Earnings came in at $490.5 million in Q1 2026, down 93.44% year-on-year from $7.5 billion in Q1 2025, and down 94.0% on a QoQ basis from $8.2 billion in Q4 2025.
Bio-Rad Laboratories (BIO) Retained Earnings (2009 - 2026) Analysis & Trends
Bio-Rad Laboratories (BIO) has 18 years of Retained Earnings data on file, last reported at $490.5 million in Q1 2026.
- On a quarterly basis, Retained Earnings fell 93.44% year-over-year to $490.5 million in Q1 2026; TTM through Mar 2026 was $490.5 million, a 93.44% decrease from a year earlier, with the FY2025 full-year figure at $8.2 billion, up 1665.18% from the prior year.
- Retained Earnings for Q1 2026 stood at $490.5 million, down from $8.2 billion in the prior quarter.
- Over the last five years, Retained Earnings for BIO reached as high as $9.6 billion in Q1 2024 and fell as low as -$845.2 million in Q3 2022.
- Historically, Retained Earnings has averaged $1.8 billion across 5 years, with a median of $9.9 million in 2023.
- Across the five-year window, Retained Earnings sank 6418.29% in 2022 and soared 95390.54% in 2024, its largest moves.
- Year by year, Retained Earnings stood at -$10.3 million in 2022, then soared by 4460.19% to $449.1 million in 2023, then increased by 3.14% to $463.2 million in 2024, then surged by 1665.18% to $8.2 billion in 2025, then tumbled by 94.0% to $490.5 million in 2026.
- Per Business Quant data, the three most recent Retained Earnings figures were $490.5 million in Q1 2026, $8.2 billion in Q4 2025, and $7.5 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -6.31 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -583.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -4.10 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 6.91 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 14.62 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.63 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -1.40 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 5.32 Bn |
| 10 | Bio-Rad Laboratories | 8.53 Bn | 6.97 Bn | 309.40 Mn | 490.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 490.50 Mn |
| Dec 31, 2025 | 8.18 Bn |
| Sep 30, 2025 | 7.46 Bn |
| Jun 30, 2025 | -154.10 Mn |
| Mar 31, 2025 | 7.48 Bn |
| Dec 31, 2024 | 463.20 Mn |
| Sep 30, 2024 | -315.27 Mn |
| Jun 30, 2024 | -451.36 Mn |
| Mar 31, 2024 | 9.64 Bn |
| Dec 31, 2023 | 449.10 Mn |
| Sep 30, 2023 | 9.90 Mn |
| Jun 30, 2023 | -374.70 Mn |
| Mar 31, 2023 | 10.10 Mn |
| Dec 31, 2022 | -10.30 Mn |
| Sep 30, 2022 | -845.20 Mn |
| Jun 30, 2022 | -518.10 Mn |
| Mar 31, 2022 | -307.90 Mn |
| Dec 31, 2021 | -175.60 Mn |
| Sep 30, 2021 | -22.20 Mn |
| Jun 30, 2021 | 8.20 Mn |